Published in J Inherit Metab Dis on October 25, 2006
Metabolic acidosis mimicking diabetic ketoacidosis after use of calorie-free mineral water. Eur J Pediatr (2012) 1.38
Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest (2009) 1.36
Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience. J Pediatr (2011) 1.27
Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects. J Inherit Metab Dis (2011) 0.98
Combining amine metabolomics and quantitative proteomics of cancer cells using derivatization with isobaric tags. Anal Chem (2014) 0.81
Defects of thiamine transport and metabolism. J Inherit Metab Dis (2014) 0.81
Movement disorders in adult surviving patients with maple syrup urine disease. Mov Disord (2011) 0.80
Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyproline. Eur J Pediatr (2008) 0.77
Quality performance of newborn screening systems: strategies for improvement. J Inherit Metab Dis (2007) 0.75
Neurocognitive profiles in MSUD school-age patients. J Inherit Metab Dis (2017) 0.75
Sensory-motor polyneuropathy occurring in variant maple syrup urine disease. J Inherit Metab Dis (2008) 0.75
Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure (2000) 1.11
Pregnancy in a woman with maple syrup urine disease. J Inherit Metab Dis (1998) 1.03
Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem (1999) 0.90
Gene preference in maple syrup urine disease. Am J Hum Genet (2000) 0.89
Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease. Pediatr Res (1989) 0.85
Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease. Pediatr Res (2001) 0.82
Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease. Pediatr Res (1991) 0.77
Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts. Biochem Med Metab Biol (1989) 0.76
Maple syrup urine disease: alpha-ketoisocaproate decarboxylation activity in different types of cultured amniotic fluid cells. Prenat Diagn (1981) 0.76
An asymptomatic variant of maple syrup urine disease without organic aciduria. J Inherit Metab Dis (1994) 0.76
Analysis of maple syrup urine disease in cell culture: use of substrates. Clin Chim Acta (1989) 0.76
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis (2009) 1.58
The dup(3q) syndrome: report of eight cases and review of the literature. Am J Med Genet (1981) 1.52
Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr (1984) 1.47
Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency. Neuropediatrics (2000) 1.44
Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta (1976) 1.44
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Proton MR spectroscopy of the lumbar spine in patients with glycogen storage disease type Ib. J Magn Reson Imaging (2001) 1.37
Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis (2009) 1.30
Restriction fragment length polymorphisms at the human parathyroid hormone gene locus. Hum Genet (1984) 1.27
Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr (1988) 1.22
On the origin of the supernumerary chromosome in autosomal trisomies--with special reference to Down's syndrome. A bias in tracing nondisjunction by chromosomal and biochemical polymorphisms. Hum Genet (1976) 1.20
Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology (1988) 1.15
Oxidation of branched chain -ketoacids in Streptococcus faecalis and it's dependence on lipoic acid. Hoppe Seylers Z Physiol Chem (1972) 1.13
Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur J Clin Invest (2004) 1.13
DNA haplotype analysis at the phenylalanine hydroxylase locus in the Turkish population. Hum Genet (1989) 1.12
A simplified method for the preparation of 14 C-labelled branched-chain -oxo acids. Biochem J (1972) 1.12
Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol (2000) 1.09
Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem (1995) 1.08
Rapid diagnosis of maple syrup urine disease (branched chain ketoaciduria) by micro-enzyme assay in leukocytes and fibroblasts. Clin Chim Acta (1973) 1.07
Social outcome in adults with maple syrup urine disease (MSUD). J Inherit Metab Dis (2007) 1.07
Estimation of pyruvate decarboxylation in perfused rat skeletal muscle. Biochem Biophys Res Commun (1983) 1.05
Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta (1983) 1.05
Mallory body-like inclusions in a hereditary congenital neuromuscular disease. Muscle Nerve (1983) 1.04
Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology (1996) 1.04
Pregnancy in a woman with maple syrup urine disease. J Inherit Metab Dis (1998) 1.03
Evidence for impaired gluconeogenesis in very long-chain acyl-CoA dehydrogenase-deficient mice. Horm Metab Res (2006) 1.02
Alpha-ketoadipic aciduria: degradation studies with fibroblasts,. Clin Chim Acta (1975) 1.02
Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab (2004) 1.02
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol (1993) 1.01
Evidence for the compartmentation of pyruvate metabolism in perfused rat skeletal muscle. Biochem J (1983) 1.01
A patient with alpha-ketoadipic and alpha-aminoadipic aciduria. J Inherit Metab Dis (1984) 0.99
Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies. Clin Chim Acta (1975) 0.99
Severe neurological crisis in a patient with hereditary tyrosinaemia type I after interruption of NTBC treatment. J Inherit Metab Dis (2008) 0.99
Liver transplantation in maple syrup urine disease. Eur J Pediatr (1999) 0.97
Hereditary ocular dysproteinhydria of the aqueous humour with crystalline deposits. Graefes Arch Clin Exp Ophthalmol (1984) 0.97
Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation. J Inherit Metab Dis (2000) 0.97
Antibiotic therapy for improvement of metabolic control in methylmalonic aciduria. J Pediatr (1990) 0.97
Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study. Eur J Pediatr (1991) 0.96
Maple syrup urine disease: analysis of branched chain ketoacid decarboxylation in cultured fibroblasts. Pediatr Res (1975) 0.96
Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease. J Inherit Metab Dis (2006) 0.96
Simple method for the routine determination of betaine and N,N-dimethylglycine in blood and urine. Clin Chem (1998) 0.95
Is demyelination a feature of maple syrup urine disease? Pediatr Neurol (1994) 0.94
Keto acids in tissues and biological fluids: O-t-butyldimethylsilyl quinoxalinols as derivatives for sensitive gas chromatographic/mass spectrometric determination. Biomed Mass Spectrom (1985) 0.94
Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Mol Genet Metab (2005) 0.93
Pitfalls in measuring plasma cholesterol in the Smith-Lemli-Opitz syndrome. Clin Chem (1997) 0.93
Intellectual performance of children with maple syrup urine disease. Eur J Pediatr (1993) 0.93
Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol (1995) 0.90
Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem (1999) 0.90
Carnitine supplementation induces long-chain acylcarnitine production--studies in the VLCAD-deficient mouse. J Inherit Metab Dis (2006) 0.89
Beta cell nesidioblastosis. Eur J Pediatr (1978) 0.89
Development of height and weight in children with diabetes mellitus: report on two prospective multicentre studies, one cross-sectional, one longitudinal. Eur J Pediatr (1992) 0.88
Diagnostic work-up and management of patients with isolated methylmalonic acidurias in European metabolic centres. J Inherit Metab Dis (2008) 0.88
Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet (1998) 0.88
Acute neuronopathic Gaucher disease complicated by fatal gastrointestinal bleeding. Neuropediatrics (2006) 0.87
Metabolism of branched-chain amino acids in maple syrup urine disease. Eur J Pediatr (1997) 0.87
Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res (2001) 0.87
Defects in the mitochondrial energy metabolism outside the respiratory chain and the pyruvate dehydrogenase complex. Mol Cell Biochem (1997) 0.87
HLA and Wolfram (DIDMOAD) syndrome. Lancet (1983) 0.87
Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations. Hum Mutat (2000) 0.87
Analysis of the fatty acid composition of erythrocyte phospholipids by a base catalysed transesterification method--prevention of formation of dimethylacetals. Clin Chim Acta (1988) 0.86
Studies on the optimal cooling rate for freezing human diploid fibroblasts. Exp Cell Res (1973) 0.86
[The AWMF model for the evaluation of published research papers in medicine. Arbeitsgemeinschaft der wissenschaftlichen medizinischen Fachgesellschaften (Working Group of the Scientific Medical Specialty Societies)]. Dtsch Med Wochenschr (1999) 0.86
[Studies on the genetics of otosclerosis (author's transl)]. HNO (1978) 0.86
Interrelation between the metabolism of L-isoleucine and L-allo-isoleucine in patients with maple syrup urine disease. Pediatr Res (1989) 0.85
Towards self-monitoring and self-treatment in phenylketonuria--a way to better diet compliance. Eur J Pediatr (1996) 0.85
A familial progressive neurodegenerative disease with 2-oxoglutaric aciduria. Eur J Pediatr (1982) 0.85
[Syndrome of blue sclerae and keratoglobus (ocular type of Ehlers-Danlos syndrome (author's transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1977) 0.85
Inheritance of metachromatic leukodystrophy. Am J Hum Genet (1977) 0.85
A form of congenital muscular dystrophy. Brain Dev (1980) 0.85
Transmission of incontinentia pigmenti from mother to son is consistent with a half chromatid back-mutation (reversion) model. Clin Genet (1982) 0.85
beta-Trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain. Biochim Biophys Acta (1999) 0.85
Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria). Eur J Pediatr (1986) 0.85
Deficiency of the voltage-dependent anion channel: a novel cause of mitochondriopathy. Pediatr Res (1996) 0.85
Importance of mitochondrial transmembrane processes in human mitochondriopathies. J Bioenerg Biomembr (1996) 0.85
Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis (2013) 0.85
Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings. Eur J Pediatr (1982) 0.85
Genetic counselling and prenatal diagnosis in disorders of the mitochondrial energy metabolism. J Inherit Metab Dis (1996) 0.84
White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur J Pediatr (1993) 0.84
Description of the mutations in 15 subjects with variant forms of maple syrup urine disease. J Inherit Metab Dis (2007) 0.84
Isolated (biotin-resistant) 3-methylcrotonyl-CoA carboxylase deficiency: four sibs devoid of pathology. J Inherit Metab Dis (1995) 0.84
Liver transplantation in two cases of propionic acidaemia. J Inherit Metab Dis (1995) 0.84
Dermatoglyphic peculiarities in families with X-linked mental retardation and fragile site Xq27: a collaborative study. Clin Genet (1986) 0.84
Molecular genetic characterization and urinary excretion pattern of metabolites in two families with MCAD deficiency due to compound heterozygosity with a 13 base pair insertion in one allele. J Inherit Metab Dis (1994) 0.84
Clinical heterogeneity in respiratory chain complex III deficiency in childhood. J Neurol Sci (1997) 0.84
Metabolic phenotypes of phenylketonuria. Kinetic and molecular evaluation of the Blaskovics protein loading test. J Inherit Metab Dis (2009) 0.83
Oxidative determination of 14C-labeled 2-oxo acids. Anal Biochem (1984) 0.83
Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease. Pediatr Res (2001) 0.82
Evaluation of a heterozygote test for maple syrup urine disease in leucocytes and cultured fibroblasts. Humangenetik (1971) 0.82
Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. J Pediatr (1991) 0.82
Prenatal detection of defects in propionate metabolism. Clin Chim Acta (1980) 0.82
[Diseases caused by genetic defects in lysosomal muco-polysaccharide-catabolism. Mucopolysaccharidoses]. Dtsch Med Wochenschr (1974) 0.82
Mitochondrial myopathy with lactic acidosis and deficient activity of muscle succinate cytochrome-c-oxidoreductase. Eur J Pediatr (1984) 0.82
Significance of diagnostic parameters in [13C]octanoic acid gastric emptying breath tests. Isotopes Environ Health Stud (1998) 0.82
3-Methylglutaconic and 3-methylglutaric aciduria in a patient with suspected 3-methylglutaconyl-CoA hydratase deficiency. Eur J Pediatr (1985) 0.82